Hemminki K, Widlak P, Hou S M
Center for Nutrition and Toxicology, Karolinska Institute, Huddinge, Sweden.
Carcinogenesis. 1995 Jul;16(7):1661-4. doi: 10.1093/carcin/16.7.1661.
DNA-binding of tamoxifen and toremifene was studied in rat in vivo, in human and rat microsomes in vitro, and in cultured primary human lymphocytes by 32P-postlabelling. Only tamoxifen caused DNA adducts in rat liver. Both compounds induced adducts in both rat and human microsomal systems and in cultured lymphocytes. The levels of adducts in microsomes and lymphocytes were low, ca. 1 adduct/10(9) nucleotides. Toremifene showed lower binding in each system, and in lymhocytes adducts were only detected at a cytotoxic dose level.
通过³²P后标记法,在大鼠体内、人及大鼠微粒体体外以及原代培养的人淋巴细胞中研究了他莫昔芬和托瑞米芬与DNA的结合情况。仅他莫昔芬在大鼠肝脏中导致DNA加合物形成。两种化合物在大鼠和人微粒体系统以及培养的淋巴细胞中均诱导加合物形成。微粒体和淋巴细胞中的加合物水平较低,约为1个加合物/10⁹个核苷酸。托瑞米芬在每个系统中的结合较低,并且仅在细胞毒性剂量水平下才在淋巴细胞中检测到加合物。